Pfizer Axes Deal For Brain Cancer Vaccine, Leaves Partner Celldex In the Lurch
This article was originally published in The Pink Sheet Daily
Executive Summary
A brave face: Celldex execs say they are ready and able to take brain cancer vaccine CDX-110 into Phase III without a Big Pharma partner.